Selskabsmeddelelse16.12.2025, 07.57Chordate Medical terminates the liquidity guarantee for the common share
Selskabsmeddelelse8.12.2025, 15.30Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Selskabsmeddelelse18.11.2025, 18.40Notice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)
Selskabsmeddelelse18.11.2025, 18.30The board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting
Pressemeddelelse19.8.2025, 06.30Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010
Selskabsmeddelelse17.7.2025, 13.45Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Selskabsmeddelelse30.6.2025, 16.45Notice of Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Selskabsmeddelelse30.6.2025, 16.30Chordate decides on a conditional directed new issue of Preference Shares of approximately SEK 2.55 million
Pressemeddelelse27.6.2025, 06.30Chordate presents conclusions from the second data monitoring of the ongoing open-label long-term study on chronic migraine: PM010
Selskabsmeddelelse23.5.2025, 06.30Chordate Medical Holding AB (publ) Interim Report January-March 2025
Selskabsmeddelelse21.5.2025, 14.15Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)
Pressemeddelelse20.5.2025, 09.00BioStock: BioStock: New distributor strengthens Chordate Medical’s investment in Saudi Arabia
Pressemeddelelse13.5.2025, 08.45Chordate Medical Expands Migraine Offering in Saudi Arabia – Appoints Additional Distributor
Selskabsmeddelelse7.5.2025, 08.55Chordate Medical terminates the liquidity provider agreement for the preference share